Blog

Puma Biotechnology PBYI reported first-quarter 2026 adjusted loss of 4 cents per share, narrower than the Zacks Consensus Estimate of a loss of 13 cents. In the year-ago quarter, the company had

AMN Healthcare Services, Inc. AMN delivered adjusted earnings per share (EPS) of $2.10 in the first-quarter 2026, up 367% year over year. The figure surpassed the Zacks Consensus Estimate by 31.3%.

Gen Digital Inc. GEN reported fourth-quarter fiscal 2026 non-GAAP earnings of 67 cents per share, topping the Zacks Consensus Estimate by 3.6%. GEN’s fourth-quarter fiscal 2026 earnings grew 13.6%

Ocugen (OCGN) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of

Investors might want to bet on American Well Corporation (AMWL), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

OFG Bancorp (OFG) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates --

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

Investors might want to bet on Graham (GHM), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock

Investors might want to bet on Leonardo DRS, Inc. (DRS), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

USANA Health Sciences (USNA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates --

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even

BILL Holdings (BILL) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Lattice Semiconductor (LSCC) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Investors might want to bet on Fortinet (FTNT), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

New York Times Co. (NYT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Sally Beauty Holdings, Inc. SBH is likely to register top-line growth when it reports second-quarter fiscal 2026 earnings on May 11, before the opening bell. The Zacks Consensus Estimate for

Babcock & Wilcox Enterprises BW is scheduled to report first-quarter 2026 results on May 11, after market close.

The Zacks Consensus Estimate for Babcock & Wilcox Enterprises’ first-quarter 2026

MasTec, Inc.’s MTZ pipeline business returning to its historical $3.5 billion revenue peak by 2027 has shifted from a distant possibility to a credible upside scenario following a transformative

Brighthouse Financial, Inc. BHF reported first-quarter 2026 adjusted net income of $4.35 per share, which missed the Zacks Consensus Estimate by 8.4%. However, the bottom line grew 4.3% year over